Company Name, Ticker, Customers, else..

Cns Pharmaceuticals Inc (NASDAQ: CNSP)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Cns Pharmaceuticals Inc 's

Name: Cns Pharmaceuticals Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CNSP Sales vs. its Competitors Q2 2026

Comparing the current results to its competitors, Cns Pharmaceuticals Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 20.07 %, recorded in the same quarter.

• List of CNSP Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Cns Pharmaceuticals Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 3.65 %

<< CNSP Stock Performance Comparisons

<< See the full list of CNSP competitors

*Market share is calculated based on total revenue.

CNSP's Stock Performance relative to its Competitors

Publicly Traded Peers of Cns Pharmaceuticals Inc

Werewolf Therapeutics Inc
Share Performance

-35.30%

One Year

Werewolf Therapeutics Inc

Profile

Werewolf Therapeutics Inc operates with a business model focused on utilizing innovative technologies to develop therapies targeting cancer using immune cell activation.

More about Werewolf Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 45.594 mill.	$ 21.000 mill.	$ -34.613 mill.

Kezar Life Sciences Inc
Share Performance

-0.82%

30 Days

Kezar Life Sciences Inc

Profile

Kezar Life Sciences Inc is a biotechnology company that focuses on developing novel small molecule therapeutics. Their business model revolves around the discovery and development of innovative drugs to target autoimmune and inflammatory disorders, aiming to address unmet medical needs. They primarily operate by conducting extensive research and conducting clinical trials to deliver effective treatments for patients.

More about Kezar Life Sciences Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 53.537 mill.	$ - mill.	$ -45.233 mill.

Terns Pharmaceuticals Inc
Share Performance

+1,504.55%

One Year

Terns Pharmaceuticals Inc

Profile

Terns Pharmaceuticals Inc. is a biopharmaceutical company.

More about Terns Pharmaceuticals Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 4,933.171 mill.	$ - mill.	$ -96.207 mill.

Actinium Pharmaceuticals Inc
Share Performance

+22.12%

30 Days

Actinium Pharmaceuticals Inc

Profile

Actinium Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of targeted therapies for the treatment of various cancers.

More about Actinium Pharmaceuticals Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 39.890 mill.	$ 35.090 mill.	$ 37.853 mill.

Oramed Pharmaceuticals Inc
Share Performance

+19.74%

This Quarter

Oramed Pharmaceuticals Inc

Profile

Oramed Pharmaceuticals Inc. is a biopharmaceutical company with a business model focused on developing innovative oral drug delivery solutions.

More about Oramed Pharmaceuticals Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 193.381 mill.	$ - mill.	$ 174.864 mill.

90 more competitors available

Sources: Cns Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 15, 2026 7:24 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cns Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.